1. Home
  2. CRGX vs TRST Comparison

CRGX vs TRST Comparison

Compare CRGX & TRST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRGX
  • TRST
  • Stock Information
  • Founded
  • CRGX 2021
  • TRST 1902
  • Country
  • CRGX United States
  • TRST United States
  • Employees
  • CRGX N/A
  • TRST N/A
  • Industry
  • CRGX
  • TRST Major Banks
  • Sector
  • CRGX
  • TRST Finance
  • Exchange
  • CRGX Nasdaq
  • TRST Nasdaq
  • Market Cap
  • CRGX 628.6M
  • TRST 612.5M
  • IPO Year
  • CRGX 2023
  • TRST N/A
  • Fundamental
  • Price
  • CRGX $3.70
  • TRST $32.33
  • Analyst Decision
  • CRGX Hold
  • TRST
  • Analyst Count
  • CRGX 7
  • TRST 0
  • Target Price
  • CRGX $4.67
  • TRST N/A
  • AVG Volume (30 Days)
  • CRGX 1.9M
  • TRST 84.1K
  • Earning Date
  • CRGX 03-20-2025
  • TRST 01-21-2025
  • Dividend Yield
  • CRGX N/A
  • TRST 4.59%
  • EPS Growth
  • CRGX N/A
  • TRST N/A
  • EPS
  • CRGX N/A
  • TRST 2.57
  • Revenue
  • CRGX N/A
  • TRST $169,773,000.00
  • Revenue This Year
  • CRGX N/A
  • TRST N/A
  • Revenue Next Year
  • CRGX N/A
  • TRST N/A
  • P/E Ratio
  • CRGX N/A
  • TRST $12.40
  • Revenue Growth
  • CRGX N/A
  • TRST N/A
  • 52 Week Low
  • CRGX $3.00
  • TRST $25.83
  • 52 Week High
  • CRGX $33.92
  • TRST $38.89
  • Technical
  • Relative Strength Index (RSI)
  • CRGX 20.88
  • TRST 41.78
  • Support Level
  • CRGX $3.00
  • TRST $31.66
  • Resistance Level
  • CRGX $3.88
  • TRST $33.00
  • Average True Range (ATR)
  • CRGX 0.92
  • TRST 0.82
  • MACD
  • CRGX -1.00
  • TRST 0.13
  • Stochastic Oscillator
  • CRGX 5.99
  • TRST 34.59

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platform technologies, and manufacturing plan are designed to directly address the key limitations of approved cell therapies, including limited durability of effect, suboptimal safety and unreliable supply. The company's program, CRG-022, is a novel CAR T-cell product candidate designed to address resistance mechanisms by targeting CD22, an alternate tumor antigen that is expressed in a vast majority of B-cell malignancies.

About TRST TrustCo Bank Corp NY

Trustco Bank Corp N Y is a savings and loan holding company. The core part of a business consists of accepting deposits and making loans and investments. It offers a range of both personal and business banking services. The company's product includes savings accounts; retirement accounts; money market account; mortgages; building loans; auto loans and others. The Company based on only one business segment, that of community banking. TrustCo lends in the geographic territory of its branch locations in New York, Florida, Massachusetts, New Jersey and Vermont.

Share on Social Networks: